PeopleBio, Inc. (KOSDAQ:304840)

PeopleBio Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	May 19, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Market Capitalization	26,471	22,631	64,567	64,666	185,487	182,777
Market Cap Growth	-56.20%	-64.95%	-0.15%	-65.14%	1.48%	-36.77%
Enterprise Value	34,442	30,962	66,421	73,663	173,842	167,284
Last Close Price	1091.00	1069.00	3070.00	3075.00	11401.96	11797.61
PS Ratio	9.29	7.94	25.51	14.52	41.73	316.73
PB Ratio	0.92	0.79	8.47	3.29	31.31	9.61
P/TBV Ratio	0.93	0.80	11.87	4.08	378.00	14.04
EV/Sales Ratio	12.08	10.86	26.25	16.54	39.11	289.88
Debt / Equity Ratio	0.27	0.27	1.21	0.13	2.76	0.72
Net Debt / Equity Ratio	0.27	0.27	0.38	-0.14	-1.06	-1.32
Net Debt / EBITDA Ratio	-0.73	-0.73	-0.41	0.20	0.61	3.87
Net Debt / FCF Ratio	-1.42	-1.42	-0.26	0.16	0.41	3.08
Asset Turnover	0.08	0.08	0.09	0.13	0.10	0.02
Inventory Turnover	1.47	1.47	0.84	2.16	7.18	5.52
Quick Ratio	0.10	0.10	0.56	2.39	0.74	1.33
Current Ratio	0.31	0.31	1.03	4.19	0.89	1.37
Return on Equity (ROE)	-69.24%	-69.24%	-67.17%	-135.86%	-120.31%	-35.50%
Return on Assets (ROA)	-21.28%	-21.28%	-19.86%	-27.27%	-15.61%	-14.59%
Return on Capital Employed (ROCE)	-39.90%	-39.90%	-82.60%	-63.40%	-123.40%	-32.80%
Earnings Yield	-59.36%	-69.44%	-16.90%	-24.80%	-7.71%	-2.57%
FCF Yield	-20.39%	-23.84%	-17.02%	-26.29%	-8.22%	-4.48%
Buyback Yield / Dilution	-0.11%	-0.11%	-31.16%	-13.30%	8.80%	-32.17%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.